Component: (Network and Table)
Network
00500 - Statement - Condensed Consolidated Statements of Cash Flows
(http://www.aegerion.com/role/StatementCondensedConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001338042 (http://www.sec.gov/CIK)
Statement of Cash Flows [Abstract]Period [Axis]
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
2013-01-01 - 2013-12-31
Statement of Cash Flows [Abstract]
 
 
 
Operating activities
 
 
 
Net loss
(73,339,000) 
(39,385,000) 
(63,358,000) 
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
 
 
 
Depreciation
1,815,000  
1,219,000  
469,000  
Amortization of intangible assets
20,183,000  
  
Amortization of premium on marketable securities
 
1,065,000  
1,904,000  
Stock-based compensation
23,993,000  
29,875,000  
27,650,000  
Noncash interest expense
20,381,000  
7,127,000  
99,000  
Provision for inventory excess and obsolescence
2,451,000  
1,548,000  
225,000  
Other non-cash losses
 
2,000  
 
Excess tax expense (benefit) from stock-based compensation
62,000  
(62,000) 
 
Unrealized foreign exchange loss
(933,000) 
  
Loss on disposal of property and equipment
66,000  
  
Deferred income taxes
501,000  
  
Deferred rent
(135,000) 
  
Changes in assets and liabilities, excluding the effect of acquisition:
 
 
 
Accounts receivable
3,568,000  
(9,563,000) 
(7,572,000) 
Inventories
2,518,000  
(10,170,000) 
(1,594,000) 
Prepaid expenses and other assets
(5,327,000) 
173,000  
(3,600,000) 
Accounts payable
1,071,000  
5,485,000  
(1,116,000) 
Accrued and other liabilities
19,106,000  
10,635,000  
8,406,000  
Net cash provided by (used in) operating activities
15,981,000  
 
(2,051,000) 
 
(38,487,000) 
 
Investing activities
 
 
 
Purchases of property and equipment
(1,879,000) 
(3,940,000) 
(716,000) 
Payment for acquisition of MYALEPT
(325,000,000) 
  
Purchases of marketable securities
 
(46,494,000) 
(77,910,000) 
Maturities of marketable securities
 
64,522,000  
53,632,000  
Sales and redemptions of marketable securities
 
46,090,000  
2,194,000  
Net cash (used in) provided by investing activities
(326,879,000) 
 
60,178,000  
 
(22,800,000) 
 
Financing activities
 
 
 
Proceeds from long-term debt, net
24,962,000  
  
Increase in restricted cash to collateralize long-term debt in default
(25,529,000) 
  
Change in restricted cash
  
105,000  
Proceeds from issuances of convertible notes
 
325,000,000  
 
Proceeds from issuances of warrants
 
60,547,000  
 
Purchase of convertible bond hedges
 
(86,645,000) 
 
Principal repayment of long-term debt
(4,010,000) 
(3,578,000) 
(3,022,000) 
Repurchase of common stock
 
(35,000,000) 
10,038,000  
Payments for withholding taxes on restricted stock units
(369,000) 
  
Proceeds from exercises of stock options
4,255,000  
3,738,000  
 
Payment of financing fees
 
(8,450,000) 
 
Excess tax expense (benefit) from stock-based compensation
(62,000) 
62,000  
 
Proceeds from issuances of common stock, net of offering expenses
  
78,020,000  
Net cash (used in) provided by financing activities
(753,000) 
 
255,674,000  
 
85,141,000  
 
Exchange rate effect on cash
215,000  
1,125,000  
(14,000) 
Net (decrease) increase in cash and cash equivalents
(311,436,000) 
 
314,926,000  
 
23,840,000  
 
Cash and cash equivalents, beginning of period
375,937,000  
61,011,000  
37,171,000  
Cash and cash equivalents, end of period
64,501,000  
 
375,937,000  
 
61,011,000  
 
Supplemental disclosures of cash flow information
 
 
 
Cash paid for interest
7,204,000  
402,000  
638,000  
Cash paid for taxes
1,319,000  
1,089,000  
115,000  
Non-cash investing activities
 
 
 
Purchases of property and equipment included in accounts payable
184,000  
122,000  
263,000